PT-141 serves as a cutting-edge cyclic melanocortin agonist that possesses potential in the treatment of sexual dysfunction. This novel compound functions by enhancing specific receptors within the body, leading to enhanced sexual response. Preclinical studies have revealed that PT-141 may effectively treat a range of sexual dysfunctions in both m